Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals
NASDAQ SPPI
$18.61 - 1.06
Day High: 19.76
Day Low: 17.82
Volume: 5,862,552
Provided by eSignal.
4:00 PM ET on Oct 19, 2017
Home > Investor Relations

Corporate Profile

Spectrum Pharmaceuticals is a leading biotechnology company with a focus in Oncology and Hematology. The Company's strategy is comprised of acquiring and developing a broad and diverse pipeline of late-stage clinical and commercial products; establishing a commercial organization for its approved drugs; continuing to build a team with people who have demonstrated skills, passion, commitment and have a track record of success in its areas of focus; and, leveraging the expertise of partners around the world to assist it in the execution of its strategy.

Spectrum Pharmaceuticals' stock is traded through the Nasdaq Global Market System.

Ticker Symbol: SPPI

Recent Releases

Poziotinib demonstrates evidence of significant antitumor activity in NSCLC patients with
Approximately $40.5 Million in Principal Amount of Notes Will Be Outstanding Following th
HENDERSON, Nev.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biote

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Contact IR

Shareholder Tools

Search IR